ivica matak
ivica matak
Znanstveni suradnik, Medicinski fakultet Sveučilišta u Zagrebu
Potvrđena adresa e-pošte na mef.hr
NaslovCitiranoGodina
Behavioral and immunohistochemical evidence for central antinociceptive activity of botulinum toxin A
I Matak, L Bach-Rojecky, B Filipović, Z Lacković
Neuroscience 186, 201-207, 2011
1362011
Botulinum toxin A, brain and pain
I Matak, Z Lacković
Progress in neurobiology 119, 39-59, 2014
912014
Botulinum toxin’s axonal transport from periphery to the spinal cord
I Matak, P Riederer, Z Lacković
Neurochemistry international 61 (2), 236-239, 2012
752012
Central action of peripherally applied botulinum toxin type A on pain and dural protein extravasation in rat model of trigeminal neuropathy
B Filipović, I Matak, L Bach-Rojecky, Z Lacković
PLoS one 7 (1), e29803, 2012
682012
Involvement of μ-opioid receptors in antinociceptive action of botulinum toxin type A
V Drinovac, L Bach-Rojecky, I Matak, Z Lacković
Neuropharmacology 70, 331-337, 2013
352013
Botulinum toxin type A selectivity for certain types of pain is associated with capsaicin-sensitive neurons
I Matak, O Rossetto, Z Lacković
PAIN® 155 (8), 1516-1526, 2014
292014
Activity of botulinum toxin type A in cranial dura: implications for treatment of migraine and other headaches
Z Lacković, B Filipović, I Matak, Z Helyes
British journal of pharmacology 173 (2), 279-291, 2016
282016
Botulinum neurotoxin type A: Actions beyond SNAP-25?
I Matak, Z Lacković
Toxicology 335, 79-84, 2015
242015
Dural neurogenic inflammation induced by neuropathic pain is specific to cranial region
B Filipović, I Matak, Z Lacković
Journal of neural transmission 121 (5), 555-563, 2014
172014
Involvement of substance P in the antinociceptive effect of botulinum toxin type A: Evidence from knockout mice
I Matak, V Tékus, K Bölcskei, Z Lacković, Z Helyes
Neuroscience 358, 137-145, 2017
92017
Comparison of analgesic effects of single versus repeated injection of botulinum toxin in orofacial formalin test in rats
I Matak, I Stracenski, Z Lacković
Journal of neural transmission 120 (1), 141-144, 2013
82013
Botulinum toxin type A in motor nervous system: unexplained observations and new challenges
I Matak, Z Lacković, M Relja
Journal of neural transmission 123 (12), 1415-1421, 2016
72016
Effects of botulinum toxin type A facial injection on monoamines and their metabolites in sensory, limbic and motor brain regions in rats
S Ibragić, I Matak, A Dračić, A Smajlović, M Muminović, F Proft, E Sofić, ...
Neuroscience letters 617, 213-217, 2016
72016
Transynaptic action of botulinum neurotoxin type A at central cholinergic boutons
M Caleo, M Spinelli, F Colosimo, I Matak, O Rossetto, Z Lackovic, ...
Journal of Neuroscience 38 (48), 10329-10337, 2018
32018
EVIDENCE FOR CENTRAL ANTISPASTIC EFFECT OF BOTULINUM TOXIN TYPE A
I Matak
British journal of pharmacology, 2019
2019
Mechanisms of Botulinum Toxin Type A Action on Pain
I Matak, K Bölcskei, L Bach-Rojecky, Z Helyes
Toxins 11 (8), 459, 2019
2019
Centrally transported botulinum toxin type A relieves local spastic paralysis
I Matak, M Relja, Z Lacković
Toxicon 156, S78, 2018
2018
Menigeal Extravasation, Efficacy of Botulinum Toxin or Triptans are not specific for Pathophysiology of Migraine only (P4. 151)
Z Lackovic, I Matak, B Filipovic, V Drinovac-Vlah, LB Rojecky
Neurology 90 (15 Supplement), P4. 151, 2018
2018
PAIN INDUCED NEUROGENIC INFLAMMATION OF THE MENINGES (P2. 150)
Z Lackovic, I Matak, B Filipovic
Neurology 88 (16 Supplement), P2. 150, 2017
2017
Role of capsaicin-sensitive neurons in bilateral antinociceptive effect of botulinum toxin type A
V Drinovac, L Bach-Rojecky, I Matak, Z Lacković
10th Forum of Neuroscience (FENS 2016), 2016
2016
Sustav trenutno ne može provesti ovu radnju. Pokušajte ponovo kasnije.
Članci 1–20